Baxter International (BAX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Baxter International (BAX)

BAX 21.06

+1.8%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Uncle Mikey who started this subject	4/15/2003 5:56:39 AM
From: pcyhuang	of 101

Buy Recommendation We recommend the purchase of Baxter International (BAX n@$20). BAX engages in the worldwide development, manufacture and distribution of products, systems and services used primarily in the health-care field. For the fiscal year ended 12/31/02, revenues rose 10% to $8.11 billion. Net income from continuing operations and before acct. chg. rose 53% to $1.03 billion. We expect BAX will earn $2.05 per share this year on revenue of $8.8 billion this year, and $2.35 per share next year. Projecting an average earnings growth rate of 15%, we estimate BAX's current PEG ratio to be .66x, substantially below those of its peers. moneycentral.msn.com. Click here for detailed company report. pcyhuang huangcapital.com Huang's Investment in Special Situations

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next